CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Inventory-to-Revenue : 0.00 (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CTT Pharmaceutical Holdings's Average Total Inventories for the quarter that ended in Jun. 2018 was $0.00 Mil. CTT Pharmaceutical Holdings's Revenue for the three months ended in Jun. 2018 was $0.00 Mil.

CTT Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Jun. 2018 stayed the same from Mar. 2018 (0.00) to Mar. 2018 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

CTT Pharmaceutical Holdings Inventory-to-Revenue Historical Data

The historical data trend for CTT Pharmaceutical Holdings's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings Inventory-to-Revenue Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Inventory-to-Revenue

Get a 7-Day Free Trial

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
Inventory-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CTT Pharmaceutical Holdings's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CTT Pharmaceutical Holdings's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's Inventory-to-Revenue falls into.

CTT Pharmaceutical Holdings Inventory-to-Revenue Calculation

CTT Pharmaceutical Holdings's Inventory-to-Revenue for the fiscal year that ended in Dec. 2015 is calculated as

	Inventory-to-Revenue (A: Dec. 2015 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2014 )	+	Total Inventories (A: Dec. 2015 ))	/	count )	/	Revenue (A: Dec. 2015 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=	N/A

CTT Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Jun. 2018 is calculated as

	Inventory-to-Revenue (Q: Jun. 2018 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Mar. 2018 )	+	Total Inventories (Q: Jun. 2018 ))	/	count )	/	Revenue (Q: Jun. 2018 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=

CTT Pharmaceutical Holdings (OTCPK:CTTH) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

CTT Pharmaceutical Holdings's Days Inventory for the three months ended in Jun. 2018 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2018 )	/	Cost of Goods Sold (Q: Jun. 2018 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

CTT Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Jun. 2018 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2018 )	/	Average Total Inventories (Q: Jun. 2018 )
	=	0	/	0
	=

CTT Pharmaceutical Holdings Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives